Recent searches
Search options
Administered by:
RT @Aiims1742@twitter.com
@drallysonocean@twitter.com That’s a great point. Many #PancreaticCancer clinical trials exist in later “lines” therapy (after progression on 1st or 2nd regimen and beyond). Having this data can allow for recruitment to such trials if the cognate molecular alteration is present. #pancchat
: TwitterAnirban Maitra on Twitter“@drallysonocean That’s a great point. Many #PancreaticCancer clinical trials exist in later “lines” therapy (after progression on 1st or 2nd regimen and beyond). Having this data can allow for recruitment to such trials if the cognate molecular alteration is present. #pancchat”